{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:41:07Z","timestamp":1791204067175,"version":"4.2.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.expneurol.2005.10.034","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T12:20:52Z","timestamp":1133871652000},"page":"275-283","source":"Crossref","is-referenced-by-count":223,"title":["Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys"],"prefix":"10.1016","volume":"197","author":[{"given":"J.","family":"Miklossy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.D.","family":"Doudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.G.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.10.034_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-8993(89)90857-3","article-title":"Microglial response to 6-hydroxydopamine-induced substantia nigra lesions","volume":"489","author":"Akiyama","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.10.034_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF00334673","article-title":"Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders","volume":"85","author":"Akiyama","year":"1993","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2005.10.034_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S0004-282X2001000100005","article-title":"Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing\u2013remitting multiple sclerosis","volume":"59","author":"Alves-Leon","year":"2001","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"10.1016\/j.expneurol.2005.10.034_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI114529","article-title":"Point mutations impairing cell surface expression of the common beta subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency","volume":"85","author":"Arnaout","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2005.10.034_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2005.10.034_bib6","first-page":"1283","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in Behcet\u2019s disease","volume":"28","author":"Boiardi","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0198-8859(01)00208-7","article-title":"Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation","volume":"62","author":"Borozdenkova","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0952-7915(94)90117-1","article-title":"Adhesion receptors in lymphocyte activation","volume":"6","author":"Collins","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0092-8674(91)90548-D","article-title":"Binding of the integrin Mac-1 (CD11b\/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation","volume":"65","author":"Diamond","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2005.10.034_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1523\/JNEUROSCI.22-03-00782.2002","article-title":"Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons","volume":"22","author":"Gao","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.10.034_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0165-6147(03)00176-7","article-title":"Novel anti-inflammatory therapy for Parkinson\u2019s disease","volume":"24","author":"Gao","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2005.10.034_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng0398-262","article-title":"A susceptibility locus for Parkinson\u2019s disease maps to chromosome 2p13","volume":"18","author":"Gasser","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2005.10.034_bib14","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.171.4.2099","article-title":"Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration","volume":"171","author":"Greenwood","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0735-1097(02)01728-X","article-title":"Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study","volume":"39","author":"Haim","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2005.10.034_bib16","doi-asserted-by":"crossref","first-page":"II58","DOI":"10.1007\/PL00007762","article-title":"Glial cells and Parkinson\u2019s disease","volume":"247","author":"Hirsch","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-5273(02)00138-9","article-title":"C\/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction","volume":"84","author":"Jiang","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/art.1780370703","article-title":"Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1","volume":"37","author":"Kavanaugh","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.expneurol.2005.10.034_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(87)90215-7","article-title":"Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency","volume":"50","author":"Kishimoto","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2005.10.034_bib20","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2003-030131","article-title":"Intercellular adhesion molecule 1 gene polymorphisms in Graves\u2019 disease","volume":"88","author":"Kretowski","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2005.10.034_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2005.10.034_bib22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib23","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.4049\/jimmunol.165.8.4658","article-title":"ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways","volume":"165","author":"Lee","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib24","first-page":"172","article-title":"Polymorphism K469E of intercellular adhesion molecule-1 gene and restenosis after coronary stenting in Chinese patients","volume":"117","author":"Liu","year":"2004","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.expneurol.2005.10.034_bib25","first-page":"553","article-title":"Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis","volume":"18","author":"Macchioni","year":"2000","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/331086a0","article-title":"Icam-1 a ligand for Lfa-1-dependent adhesion of B-cells, T-cells and myeloid cells","volume":"331","author":"Makgoba","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2005.10.034_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(87)90104-8","article-title":"Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)","volume":"51","author":"Marlin","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2005.10.034_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.52.1.75","article-title":"Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population","volume":"52","author":"Matsuzawa","year":"2003","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2005.10.034_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2005.10.034_bib31","first-page":"83","article-title":"Inflammation in Parkinson\u2019s disease","volume":"86","author":"McGeer","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(02)00300-2","article-title":"Association of interleukin-1 beta polymorphisms with idiopathic Parkinson\u2019s disease","volume":"326","author":"McGeer","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.10.034_bib30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.10.034_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.10.034_bib35","first-page":"143","article-title":"Cytokines in Parkinson\u2019s disease","author":"Nagatsu","year":"2000","journal-title":"J. Neural.,"},{"key":"10.1016\/j.expneurol.2005.10.034_bib36","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(03)14847-7","article-title":"Association of intercellular adhesion molecule-1 gene with type 1 diabetes","volume":"362","author":"Nejentsev","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2005.10.034_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0198-8859(02)00825-X","article-title":"Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis","volume":"64","author":"Nejentsev","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(98)00779-6","article-title":"Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina","volume":"83","author":"Ogawa","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0301-0082(02)00127-2","article-title":"An inflammatory review of Parkinson\u2019s disease","volume":"68","author":"Orr","year":"2002","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.dld.2004.03.015","article-title":"Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease","volume":"36","author":"Papa","year":"2004","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.expneurol.2005.10.034_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(02)00337-3","article-title":"Association between intercellular adhesion molecule-1 E\/K gene polymorphism and probable vascular dementia in humans","volume":"326","author":"Pola","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2005.10.034_bib42","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.STR.0000062346.70983.DF","article-title":"Synergistic effect of -174 G\/C polymorphism of the interleukin-6 gene promoter and 469 E\/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke","volume":"34","author":"Pola","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2005.10.034_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0197-4580(02)00087-8","article-title":"Intercellular adhesion molecule-1 K469E gene polymorphism and Alzheimer\u2019s disease","volume":"24","author":"Pola","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2005.10.034_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0891988704269822","article-title":"Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer\u2019s disease","volume":"17","author":"Rentzos","year":"2004","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(93)90023-R","article-title":"Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood\u2013cerebrospinal fluid barrier","volume":"47","author":"Rieckmann","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4049\/jimmunol.137.4.1270","article-title":"A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1","volume":"137","author":"Rothlein","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.141.5.1665","article-title":"Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies","volume":"141","author":"Rothlein","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2005.10.034_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0304-3940(02)00301-4","article-title":"Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson\u2019s disease","volume":"326","author":"Schulte","year":"2002","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.expneurol.2005.10.034_bib49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF03343586","article-title":"Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves\u2019 disease","volume":"22","author":"Sonnet","year":"1999","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.expneurol.2005.10.034_bib50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson\u2019s disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.expneurol.2005.10.034_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605003730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605003730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T19:56:21Z","timestamp":1683316581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488605003730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0014488605003730"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.10.034","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}